{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:00:59Z","timestamp":1745899259800,"version":"3.40.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,27]]},"DOI":"10.7759\/cureus.83102","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:34:26Z","timestamp":1745822066000},"source":"Crossref","is-referenced-by-count":0,"title":["Ocrelizumab-Induced Hemophagocytic Lymphohistiocytosis: A Case Report"],"prefix":"10.7759","author":[{"given":"Tajudeen","family":"Musbau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyae Phyo","family":"Thinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanusha","family":"Jeyanithi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka GE","year":"2013","unstructured":"Janka GE, Lehmberg K. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment. Hematology Am Soc Hematol Educ Program. 2013, 2013:605-11. 10.1182\/asheducation-2013.1.605","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13432","article-title":"Incidence and survival of haemophagocytic lymphohistiocytosis: a population-based cohort study from England","volume":"291","author":"West J","year":"2022","unstructured":"West J, Card TR, Bishton MJ, et al.. Incidence and survival of haemophagocytic lymphohistiocytosis: a population-based cohort study from England. J Intern Med. 2022, 291:493-504. 10.1111\/joim.13432","journal-title":"J Intern Med"},{"key":"ref3","article-title":"Diagnosis and Management of Haemophagocytic Lymphohistiocytosis (HLH)","year":"2024","unstructured":"Diagnosis and Management of Haemophagocytic Lymphohistiocytosis (HLH). University College London Hospitals NHS Foundation Trust, London, England; 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21423","article-title":"Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis","volume":"50","author":"Allen CE","year":"2008","unstructured":"Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008, 50:1227-35. 10.1002\/pbc.21423","journal-title":"Pediatr Blood Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet L","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, et al.. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014, 66:2613-20. 10.1002\/art.38690","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000127779.24232.15","article-title":"Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients\u2014a postmortem clinicopathologic analysis","volume":"32","author":"Strauss R","year":"2004","unstructured":"Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG. Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients\u2014a postmortem clinicopathologic analysis. Crit Care Med. 2004, 32:1316-21. 10.1097\/01.ccm.0000127779.24232.15","journal-title":"Crit Care Med"},{"key":"ref7","article-title":"Familial hemophagocytic lymphohistiocytosis","author":"Zhang K","year":"1993","unstructured":"Zhang K, Astigarraga I, Bryceson Y, et al.. Familial hemophagocytic lymphohistiocytosis. GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle (WA); 1993."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1352458521993070","article-title":"Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis","volume":"27","author":"Machla\u0144ska A","year":"2021","unstructured":"Machla\u0144ska A, Helbig G, Chromik K, Zapa\u0142a M, Zwiernik B, Selmaj K. Hemophagocytic lymphohistiocytosis associated with ocrelizumab treatment in a patient with multiple sclerosis. Mult Scler. 2021, 27:1803-5. 10.1177\/1352458521993070","journal-title":"Mult Scler"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363614-ocrelizumab-induced-hemophagocytic-lymphohistiocytosis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T06:34:30Z","timestamp":1745822070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363614-ocrelizumab-induced-hemophagocytic-lymphohistiocytosis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,27]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.83102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,27]]}}}